Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Circassia Limited
With
inVentiv Health Clinical
Pharm-Olam International
Age
12–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female, aged 12-65 years.
Moderate to severe rhinoconjunctivitis on exposure to cats for at least 2 years.
Subjects may optionally also have GINA Step 1 controlled asthma.
Positive skin prick test to cat hair.
Cat dander specific IgE ≥0.35 kU/L.
You may not be if
Asthma falling under the GINA definitions "partly controlled" and "uncontrolled" or Steps 2 to 5.
FEV1 \<80% of predicted.
Clinically significant confounding symptoms of allergy to seasonal allergens during the final evaluation period.
Skin prick test 5 mm greater than the negative control to perennial allergens or animal dander (other than cat) which cannot be avoided during the study.
Significant symptoms of another clinically relevant illness that is likely to affect scoring of rhinoconjunctivitis symptoms.
Clinically relevant abnormalities detected on physical examination.
History of severe drug allergy, severe angioedema or anaphylactic reaction to food.
